On Monday, Theravance Biopharma Inc (NASDAQ: TBPH) was 3.74% up from the session before settling in for the closing price of $17.39. A 52-week range for TBPH has been $7.90 – $18.96.
Healthcare Sector giant saw their annual sales surged by 22.95% over the last five years. When this article was written, the company’s average yearly earnings per share was at 256.38%. With a float of $47.11 million, this company’s outstanding shares have now reached $50.67 million.
Theravance Biopharma Inc (TBPH) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Theravance Biopharma Inc stocks. The insider ownership of Theravance Biopharma Inc is 7.04%, while institutional ownership is 96.44%. The most recent insider transaction that took place on Nov 11 ’25, was worth 809,250. Before that another transaction happened on Jul 14 ’25, when Company’s SVP, COMM & MEDICAL AFFAIRS sold 10,000 for $11.39, making the entire transaction worth $113,870. This insider now owns 326,918 shares in total.
Theravance Biopharma Inc (TBPH) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.05 earnings per share (EPS) during the time that was better than consensus figure (set at -0.08) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.
Theravance Biopharma Inc (NASDAQ: TBPH) Trading Performance Indicators
You can see what Theravance Biopharma Inc (TBPH) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 9.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.38. Likewise, its price to free cash flow for the trailing twelve months is 3.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.56, a number that is poised to hit 0.85 in the next quarter and is forecasted to reach 0.88 in one year’s time.
Technical Analysis of Theravance Biopharma Inc (TBPH)
Analysing the last 5-days average volume posted by the [Theravance Biopharma Inc, TBPH], we can find that recorded value of 0.84 million was better than the volume posted last year of 0.31 million. As of the previous 9 days, the stock’s Stochastic %D was 74.27%.
During the past 100 days, Theravance Biopharma Inc’s (TBPH) raw stochastic average was set at 88.70%, which indicates a significant increase from 81.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.88 in the past 14 days, which was higher than the 0.48 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.63, while its 200-day Moving Average is $11.46. Now, the first resistance to watch is $18.54. This is followed by the second major resistance level at $19.05. The third major resistance level sits at $19.69. If the price goes on to break the first support level at $17.39, it is likely to go to the next support level at $16.75. Now, if the price goes above the second support level, the third support stands at $16.24.
Theravance Biopharma Inc (NASDAQ: TBPH) Key Stats
There are 50,672K outstanding shares of the company, which has a market capitalization of 914.13 million. As of now, sales total 64,380 K while income totals -56,420 K. Its latest quarter income was 26,200 K while its last quarter net income were 54,840 K.
